119 related articles for article (PubMed ID: 22554863)
1. Transepithelial transport of biperiden hydrochloride in Caco-2 cell monolayers.
Abalos IS; Rodríguez YI; Lozano V; Cereseto M; Mussini MV; Spinetto ME; Chiale C; Pesce G
Environ Toxicol Pharmacol; 2012 Sep; 34(2):223-227. PubMed ID: 22554863
[TBL] [Abstract][Full Text] [Related]
2. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
3. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.
Yang Y; Faustino PJ; Volpe DA; Ellison CD; Lyon RC; Yu LX
Mol Pharm; 2007; 4(4):608-14. PubMed ID: 17637014
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
[TBL] [Abstract][Full Text] [Related]
6. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
7. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver.
Smetanová L; Stĕtinová V; Svoboda Z; Kvetina J
Acta Medica (Hradec Kralove); 2011; 54(1):3-8. PubMed ID: 21542416
[TBL] [Abstract][Full Text] [Related]
8. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
9. Biopharmaceutics permeability classification of lorcaserin, a selective 5-hydroxytryptamine 2C agonist: method suitability and permeability class membership.
Chen C; Ma MG; Fullenwider CL; Chen WG; Sadeque AJ
Mol Pharm; 2013 Dec; 10(12):4739-45. PubMed ID: 24102111
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay.
Thiel-Demby VE; Humphreys JE; St John Williams LA; Ellens HM; Shah N; Ayrton AD; Polli JW
Mol Pharm; 2009; 6(1):11-8. PubMed ID: 19248229
[TBL] [Abstract][Full Text] [Related]
11. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
12. Biowaiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride.
Kortejärvi H; Yliperttula M; Dressman JB; Junginger HE; Midha KK; Shah VP; Barends DM
J Pharm Sci; 2005 Aug; 94(8):1617-25. PubMed ID: 15959881
[TBL] [Abstract][Full Text] [Related]
13. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
[TBL] [Abstract][Full Text] [Related]
14. Purely in silico BCS classification: science based quality standards for the world's drugs.
Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL
Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040
[TBL] [Abstract][Full Text] [Related]
15. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.
Kasim NA; Whitehouse M; Ramachandran C; Bermejo M; Lennernäs H; Hussain AS; Junginger HE; Stavchansky SA; Midha KK; Shah VP; Amidon GL
Mol Pharm; 2004 Jan; 1(1):85-96. PubMed ID: 15832504
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets.
Vaithianathan S; Raman S; Jiang W; Ting TY; Kane MA; Polli JE
Mol Pharm; 2015 Jul; 12(7):2436-43. PubMed ID: 26001027
[TBL] [Abstract][Full Text] [Related]
18. Matrix effects of the hydroethanolic extract and the butanol fraction of calyces from Physalis peruviana L. on the biopharmaceutics classification of rutin.
Domínguez Moré GP; Feltrin C; Brambila PF; Cardona MI; Echeverry SM; Simões CMO; Aragón DM
J Pharm Pharmacol; 2020 May; 72(5):738-747. PubMed ID: 32162346
[TBL] [Abstract][Full Text] [Related]
19. Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification.
Liu Y; Li X; Zhang Y; Huang J; Wu Y; Wang L
J Vet Pharmacol Ther; 2020 Mar; 43(2):179-188. PubMed ID: 32039497
[TBL] [Abstract][Full Text] [Related]
20. Effect of common excipients on Caco-2 transport of low-permeability drugs.
Rege BD; Yu LX; Hussain AS; Polli JE
J Pharm Sci; 2001 Nov; 90(11):1776-86. PubMed ID: 11745735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
